Literature DB >> 15815890

[The value of clinical infectology].

M Battegay1, U Flückiger.   

Abstract

Infectious diseases specialists are involved in patient care mostly regarding patients with severe infections in complex situations. Morbidity and mortality of severe infections such as sepsis has been significantly reduced during past years and decades. Prognosis of severe infections is dependent upon timely and correct diagnosis and appropriate therapy. The diagnostic and therapeutic approach is often invasive and interdisciplinary. Importantly, thoughtful use of antibiotics may increase its effectiveness, reduce antibiotic use and occurrence of bacterial resistance and increase cost effectiveness. Hence, antibiotic management and stewardship has become more and more the focus of work. This article highlights the clinical work of infectious diseases specialists in an interdisciplinary setting and describes there value to patients and hospitals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15815890     DOI: 10.1007/s00108-005-1402-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  19 in total

1.  Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia.

Authors:  B Byl; P Clevenbergh; F Jacobs; M J Struelens; F Zech; A Kentos; J P Thys
Journal:  Clin Infect Dis       Date:  1999-07       Impact factor: 9.079

2.  Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus.

Authors:  S Harbarth; N Liassine; S Dharan; P Herrault; R Auckenthaler; D Pittet
Journal:  Clin Infect Dis       Date:  2000-11-10       Impact factor: 9.079

Review 3.  Implementing practice guidelines for appropriate antimicrobial usage: a systematic review.

Authors:  P A Gross; D Pujat
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

4.  Infectious diseases consultative recommendations: if heard, they can be listened to.

Authors:  Marvin J Tenenbaum
Journal:  Clin Infect Dis       Date:  2004-04-14       Impact factor: 9.079

5.  Early participation in an HIV cohort study slows disease progression and improves survival. The Swiss HIV Cohort Study.

Authors:  M Battegay; M Wirz; M H Steuerwald; M Egger
Journal:  J Intern Med       Date:  1998-12       Impact factor: 8.989

6.  The influence of the opinion of an infectious disease consultant on the appropriateness of antibiotic treatment in a general hospital.

Authors:  J Gómez; S J Conde Cavero; J L Hernández Cardona; M L Núñez; J Ruiz Gómez; M Canteras; M Valdés
Journal:  J Antimicrob Chemother       Date:  1996-08       Impact factor: 5.790

7.  Osteomyelitis: etiology, diagnosis, treatment and outcome in a public versus a private institution.

Authors:  F Lobati; B Herndon; D Bamberger
Journal:  Infection       Date:  2001-12       Impact factor: 3.553

8.  Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection.

Authors:  G Elhanan; M Sarhat; R Raz
Journal:  J Infect       Date:  1997-11       Impact factor: 6.072

9.  Changes in the epidemiology of pneumococcal bacteremia in a Swiss university hospital during a 15-year period, 1986-2000.

Authors:  Andrej Trampuz; Andreas F Widmer; Ursula Fluckiger; Monika Haenggi; Reno Frei; Werner Zimmerli
Journal:  Mayo Clin Proc       Date:  2004-05       Impact factor: 7.616

10.  Clinical impact of rapid in vitro susceptibility testing and bacterial identification.

Authors:  G V Doern; R Vautour; M Gaudet; B Levy
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.